Organ transplantation Surgery Transplanted organ and tissue status
Conditions
Interventions
Control arm: cannulae will be placed in the aorta and vena cava and cold Soltran™ preservation solution perfused through the abdominal organs, following which they will be removed. Duration: 30 to 60
Sponsors
Cambridge University Hospitals NHS Foundation Trust (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Individuals dying on an intensive care unit diagnosed by cardiac criteria and becoming solid organ donors 2. Deceased donors: aged 18 to 70 years, either sex; Recipients: aged 18 to 75 years, either sex
Exclusion criteria
Exclusion criteria: Time from withdrawal of treatment to death over 2 hours
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of potential organs used for transplantation | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured at 3 months: 1. Measures of function in the first week post-transplantation 2. Graft and patient survival for liver, kidney and pancreas | — |
Countries
United Kingdom
Outcome results
None listed